{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:42:10Z","timestamp":1790948530863,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejso.2021.02.024","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T02:11:12Z","timestamp":1614305472000},"page":"2166-2172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9726-9732","authenticated-orcid":false,"given":"Sylvie","family":"Bonvalot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Wunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-3534","authenticated-orcid":false,"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Martin","family":"Broto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-899X","authenticated-orcid":false,"given":"Robert","family":"Turcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rastrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Papai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-3641","authenticated-orcid":false,"given":"Stefano","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-8264","authenticated-orcid":false,"given":"Lars H.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Shumelinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cubillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Demaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"Strens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Nalbantov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2021.02.024_bib1","first-page":"7","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin. 2020"},{"key":"10.1016\/j.ejso.2021.02.024_bib2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/annonc\/mdz124","article-title":"Surgery in reference centers improves survival of sarcoma patients: a nationwide study","volume":"30","author":"Blay","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib3","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.6004\/jnccn.2018.0025","article-title":"Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"von Mehren","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ejso.2021.02.024_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1996.14.3.859","article-title":"Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma","volume":"14","author":"Pisters","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1998.16.1.197","article-title":"Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity","volume":"16","author":"Yang","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jamaoncol.2017.4996","article-title":"Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial","volume":"4","author":"Issels","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib8","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","article-title":"Improved survival using specialized multidisciplinary board in sarcoma patients","volume":"28","author":"Blay","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2015.09.021","article-title":"Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting","volume":"53","author":"Wardelmann","year":"2016","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2021.02.024_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijrobp.2017.02.087","article-title":"Histologic appearance after preoperative radiation therapy for soft tissue sarcoma: assessment of the European organization for research and treatment of cancer\u2013soft tissue and bone sarcoma group response Score","volume":"98","author":"Schaefer","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2021.02.024_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/cco.2018.05.02","article-title":"Preoperative radiotherapy in soft tissue sarcoma: from general guidelines to personalized medicine","volume":"7","author":"Haas","year":"2018","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/PAS.0000000000001214","article-title":"Histologic response to neoadjuvant therapy is not predictive of favorable outcomes in high-grade pleomorphic soft tissue sarcoma","volume":"43","author":"Cates","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2021.02.024_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00432-019-02885-4","article-title":"Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma","volume":"145","author":"Gannon","year":"2019","journal-title":"J\u00a0Canc Res Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12957-018-1462-y","article-title":"Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304","volume":"16","author":"Tanaka","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.05.007","article-title":"Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: a systematic review and meta-analysis","volume":"69","author":"Salah","year":"2018","journal-title":"Canc Treat Rev"},{"key":"10.1016\/j.ejso.2021.02.024_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jso.23775","article-title":"Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma","volume":"111","author":"Vaynrub","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.2014.635","article-title":"Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma","volume":"112","author":"Andreou","year":"2015","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2021.02.024_bib18","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1002\/cncr.28945","article-title":"Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy","volume":"120","author":"Mullen","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.02.024_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.blo.0000238864.69486.59","article-title":"Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma","volume":"455","author":"Menendez","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ejso.2021.02.024_bib20","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2001.19.13.3203","article-title":"Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas","volume":"19","author":"Eilber","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.ejso.2021.02.024_bib22","first-page":"103","article-title":"Relevance of pathological complete response after neoadjuvant therapy for breast cancer","volume":"10","author":"Pennisi","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejso.2021.02.024_bib23","author":"Services USDoHaH"},{"key":"10.1016\/j.ejso.2021.02.024_bib24","unstructured":"Services USDoHaH. Guidance for industry. Pathological complete response in neoadjuvant treatment of high-risk early-stage breast cancer: use as an endpoint to support accelerated approval 2014."},{"key":"10.1016\/j.ejso.2021.02.024_bib25","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.ejca.2005.07.023","article-title":"Differential sensitivity of liposarcoma subtypes to chemotherapy","volume":"41","author":"Jones","year":"2005","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2021.02.024_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2010.10.007","article-title":"Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma","volume":"97","author":"Roberge","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib27","article-title":"Dose reduction of preoperative radiotherapy in myxoid liposarcoma: a nonrandomized controlled trial","author":"Lansu","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(16)00010-3","article-title":"Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis","volume":"17","author":"Callegaro","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/annonc\/mdn723","article-title":"Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma","volume":"20","author":"Kim","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib30","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/1471-2407-14-666","article-title":"Postoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejso.2021.02.024_bib31","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1002\/cncr.29575","article-title":"Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: a multi-institutional study","volume":"121","author":"Ogura","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.02.024_bib32","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S1470-2045(19)30326-2","article-title":"NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial","volume":"20","author":"Bonvalot","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.02.024_bib33","first-page":"3911","article-title":"Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma","volume":"32","author":"Shah","year":"2012","journal-title":"Anticancer Res"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:38:42Z","timestamp":1760060322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0748798321001153"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.02.024","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}